These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4649556)

  • 21. A comparative study of the effectiveness of 'standard' and 'AFIP' typhoid vaccines.
    Burney MI; Ahmed A; Karamat KA
    J Pak Med Assoc; 1980 Mar; 30(3):66-8. PubMed ID: 6770126
    [No Abstract]   [Full Text] [Related]  

  • 22. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. XII. AGGLUTINATING ANTIBODIES IN RABBIT SERA AFTER THE IMMUNIZATION WITH ANTITYPHOID VACCINES].
    MEISLOWA P; RABCZYNSKA F; KUDELSKI Z
    Przegl Epidemiol; 1963; 17():81-7. PubMed ID: 14054902
    [No Abstract]   [Full Text] [Related]  

  • 23. [The seroprotective test in chick embryos as a method of evaluation of the oral immunizing effectiveness of inactivated TAB vaccine].
    Dimache G
    Microbiol Parazitol Epidemiol (Bucur); 1971; 16(6):519-24. PubMed ID: 5134756
    [No Abstract]   [Full Text] [Related]  

  • 24. Anaphylactoid reaction to typhoid-paratyphoid A and B vaccine.
    Khan RI
    Trop Geogr Med; 1971 Mar; 23(1):115-6. PubMed ID: 5573579
    [No Abstract]   [Full Text] [Related]  

  • 25. The sensitizing effect of various typhoid vaccines as revealed under experimental conditions.
    Melikova EN; Lesnjak SV
    Bull World Health Organ; 1969; 40(3):395-9. PubMed ID: 5306623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Research on the oral antityphoid immunization in mice and its mechanism of action.
    De Barbieri A; Tassi CG; Crovari P; Chiappino G
    Prog Immunobiol Stand; 1970; 4():386-8. PubMed ID: 4991590
    [No Abstract]   [Full Text] [Related]  

  • 27. Duration of postvaccination antityphoid immunity according to the results of strictly controlled field trials.
    Hejfets LB
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):154-65. PubMed ID: 5817422
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative studies with heat-inactivated corpusclar typhoid-paratyphoid vaccines without preservation or preserved with phenol].
    Dimache G; Vlădoianu IR; Dimache V; Buzdugan I; Bînzar V; Naciu C; Harasîm T
    Arch Roum Pathol Exp Microbiol; 1967 Dec; 26(4):747-60. PubMed ID: 5605451
    [No Abstract]   [Full Text] [Related]  

  • 29. Typhoid vaccination and IgA nephropathy.
    Owda AK; Turney JH
    Nephrol Dial Transplant; 1995; 10(8):1477-8. PubMed ID: 8538959
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antityphoid vaccination by the oral route. Experimental research, clinical and epidemiologic results].
    Stickl H; Marder E; Raettig H
    Cah Coll Med Hop Paris; 1968 Oct; 9(11):963-5. PubMed ID: 5748373
    [No Abstract]   [Full Text] [Related]  

  • 31. [Seroprotection of chick embryos against infection with Salmonella of the typhoid-paratyphoid group. Attempts to improve the method and possibilities of its applications in the study of immunity].
    Vlădoianu IR; Dimache G
    Arch Roum Pathol Exp Microbiol; 1966 Jun; 25(2):513-22. PubMed ID: 5985369
    [No Abstract]   [Full Text] [Related]  

  • 32. The protective activity of various antigen complexes of typhoid and paratyphoid B vaccines: controlled field trials and laboratory studies.
    Hejfets LB; Levina LA; Bentsianova TG; Salmin LV
    Prog Immunobiol Stand; 1970; 4():561-70. PubMed ID: 4991591
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental studies on various types of oral typhoid vaccines in animals and man].
    Saletti M; Panero C; Genna G; Riparbelli G; Morgese G
    Prog Immunobiol Stand; 1970; 4():372-9. PubMed ID: 5482183
    [No Abstract]   [Full Text] [Related]  

  • 34. Characteristics of the attenuated oral vaccine strain "S. typhi" Ty 21a.
    Germanier R; Fürer E
    Dev Biol Stand; 1983; 53():3-7. PubMed ID: 6873472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Abdominal typhoid following vaccination with the attenuated vaccine Vivotif].
    Straumann A; Gyr N; Thommen A; Müller R
    Schweiz Med Wochenschr; 1983 Aug; 113(34):1205. PubMed ID: 6623044
    [No Abstract]   [Full Text] [Related]  

  • 36. Acute transverse myelitis following typhoid vaccination.
    Das RN; Jaykumar J
    Ulster Med J; 2007 Jan; 76(1):39-40. PubMed ID: 17288305
    [No Abstract]   [Full Text] [Related]  

  • 37. [On disorders of the nervous system after vaccination].
    Ivanus IA
    Voen Med Zh; 1968 Mar; 3():67-8. PubMed ID: 5702896
    [No Abstract]   [Full Text] [Related]  

  • 38. [Apropos of antityphoid vaccination].
    MOULIS A
    Toulouse Med; 1963; 64():623-4. PubMed ID: 13936308
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity and safety of Vi capsular polysaccharide typhoid vaccine in healthy persons in Korea.
    Lim SM; Jung HS; Kim MJ; Park DW; Kim WJ; Cheong HJ; Park SC; Lee KC; Shin YK; Tan HK; Kim SL; Sohn JW
    J Microbiol Biotechnol; 2007 Apr; 17(4):611-5. PubMed ID: 18051272
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative assessment of the reaction-producing potential and effectiveness of vaccines proposed for prophylaxis of typhoid and paratyphoid B (main results of an epidemiologic trial conducted in 1962).
    Kheifets LB; Salmin LV; Leitman MZ; Kuz'minova ML; Vasil'eva AV; Slavina AM; Levina LA
    Fed Proc Transl Suppl; 1966; 25(4):687-91. PubMed ID: 5331526
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.